Cooper Financial Group’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-457
| Closed | -$219K | – | 317 |
|
|
2023
Q1 | $219K | Buy |
+457
| New | +$219K | 0.06% | 275 |
|
|
2022
Q1 | – | Sell |
-811
| Closed | -$613K | – | 249 |
|
|
2021
Q4 | $613K | Buy |
811
+10
| +1% | +$7.56K | 0.23% | 101 |
|
|
2021
Q3 | $598K | Buy |
801
+59
| +8% | +$44K | 0.12% | 115 |
|
|
2021
Q2 | $478K | Buy |
742
+41
| +6% | +$26.4K | 0.1% | 126 |
|
|
2021
Q1 | $400K | Sell |
701
-14
| -2% | -$7.99K | 0.09% | 146 |
|
|
2020
Q4 | $417K | Sell |
715
-19
| -3% | -$11.1K | 0.09% | 173 |
|
|
2020
Q3 | $378K | Sell |
734
-54
| -7% | -$27.8K | 0.11% | 130 |
|
|
2020
Q2 | $356K | Buy |
+788
| New | +$356K | 0.12% | 125 |
|